AMD shares gain as high AI expectations outweigh embedded sales concernsProactive Investors • 11/01/23
AMD Surpasses Q3 Earnings and Revenue Estimates, but Guidance Adds Fears About Future AI OpportunitiesThe Motley Fool • 11/01/23
Ashvattha Therapeutics Announces First Patient Dosed via Subcutaneous Administration of Anti-Angiogenic Therapeutic D-4517.2 for Wet AMD and DME in Phase 2 Chronic Dosing StudyGlobeNewsWire • 11/01/23
AMD makes bold prediction for its AI chips — but it's actually not so far-fetchedMarket Watch • 11/01/23
Advanced Micro (AMD) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 10/31/23